Table 3.
Gastric cancer | |||||
Country/Region | Database | Area of research | Sample size | Design, statistical methods and 3V | Application |
Taiwan, China | Taiwan National Health Insurance Database (NHID) | GC | 80255 | Nationwide retrospective cohort study | Early vs late H. pylori eradication on GC risk |
Wu et al[46], 2009 | |||||
Comparison with general population to derive SIR | |||||
Volume, Velocity and Variety | |||||
GC | 52161 | Nationwide retrospective cohort study | Association between NSAIDs and GC | ||
Wu et al[48], 2010 | |||||
Comparison with general population to derive SIR | |||||
Volume, Velocity and Variety | |||||
Hong Kong, China | Clinical Data Analysis and Reporting System (CDARS) | GC | 63397 | Territory-wide retrospective cohort study | Association between PPIs and GC |
Cheung et al[51], 2018 | |||||
PS regression adjustment | |||||
Volume, Velocity and Variety | |||||
GC | 63605 | Territory-wide retrospective cohort study | Association between aspirin and GC | ||
Cheung et al[49], 2018 | |||||
PS regression adjustment | |||||
Volume, Velocity and Variety | |||||
GC | 63397 | Territory-wide retrospective cohort study | Effect of H. pylori eradication among different age groups | ||
Leung et al[47], 2018 | |||||
Comparison with general population to derive SIR | |||||
Volume, Velocity and Variety | |||||
GC | 7266 | Territory-wide retrospective cohort study | Association between metformin and GC | ||
Cheung et al[50], 2018 | |||||
PS regression adjustment | |||||
Sensitivity analysis: PS weighting by IPTW and PS matching | |||||
Volume, Velocity and Variety | |||||
Sweden | Swedish Cancer Registry | GC | 797067 | Nationwide retrospective cohort study | Association between PPIs and GC |
Brusselaers et al[53], 2017 | |||||
Swedish Prescribed Drug Registry | Comparison with general population to derive SIR | ||||
Volume, Velocity and Variety | |||||
GC | 95176 | Nationwide retrospective cohort study | Effect of H. pylori eradication on GC risk | ||
Doorakkers et al[45], 2018 | |||||
Comparison with general population to derive SIR | |||||
Volume, Velocity and Variety | |||||
United States | Kaiser Permanente (KP) | GC | 61684 | Retrospective cohort study | Association between different PPIs and GC |
Schneider et al[55], 2016 | |||||
Volume, Velocity and Variety |
This list is not exhaustive, but serves to provide a few distinct examples of how Big Data analysis can generate high-quality research outputs in the field of gastroenterology and hepatology. 3V: Volume/velocity/variety; GC: Gastric cancer; SIR: Standardized incidence ratio; H. pylori: Helicobacter pylori; NSAIDs: Non-steroidal anti-inflammatory drugs; PS: Propensity score; PPIs: Proton pump inhibitors; IPTW: Inverse probability of treatment weighting.